top of page
The Professional Network for Healthcare Experts
Biocytogen and Whitehawk Partner to Advance Next-Generation Bispecific ADCs
The collaboration combines Biocytogen’s fully human antibody discovery platform with Whitehawk’s ADC expertise to develop novel cancer therapies with enhanced targeting potential.
nuaxia
Jul 93 min read
Novo Nordisk Explores Long-Acting Semaglutide Implant Through Vivani Partnership
The collaboration will evaluate Vivani’s implantable semaglutide technology as Novo Nordisk looks to expand treatment options beyond once-weekly injections.
nuaxia
Jul 93 min read
Vivani Spins Out Brain-Computer Interface Business Through Nasdaq Reverse Merger
The reverse merger will create Nasdaq-listed Cortigent Holdings, providing Vivani's brain-computer interface business with independent funding to accelerate vision restoration and neurorehabilitation technologies.
nuaxia
Jul 33 min read
bottom of page